A New Opportunity for Narcolepsy Patients

Acknowledgment: This story is sponsored by Takeda and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant, vetted and valuable information to the…

Continue Reading A New Opportunity for Narcolepsy Patients
Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome
source: pixabay.com

Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome

As we've learned more about individuals facing long-term symptoms from COVID-19, we have heard more and more about how it mimics other chronic conditions. For instance, those suffering from chronic…

Continue Reading Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome
Phase 2 PRA023 Trial for UC Begins
source: pixabay.com

Phase 2 PRA023 Trial for UC Begins

Clinical trials are important research tools to help understand the safety, efficacy, and tolerability of potential treatments. According to a news release from July 19, 2021, biotechnology company Prometheus Biosciences,…

Continue Reading Phase 2 PRA023 Trial for UC Begins
Mepsevii for MPS VII Reimbursement Approval Available in Spain
source: pixabay.com

Mepsevii for MPS VII Reimbursement Approval Available in Spain

According to a recent news release from biopharmaceutical company Ultragenyx Pharmaceutical Inc. ("Ultragenyx"), the company's therapy Mepsevii (vestronidase alfa) was approved in Spain for reimbursement. The entire reimbursement process takes…

Continue Reading Mepsevii for MPS VII Reimbursement Approval Available in Spain